v3.25.2
Condensed Statements of Operations and Comprehensive Loss - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Jun. 30, 2025
Jun. 30, 2024
Operating expenses        
Research and development $ 33,558 $ 30,680 $ 70,315 $ 58,374
General and administrative 9,052 7,427 18,254 14,486
Total operating expenses 42,610 38,107 88,569 72,860
Loss from operations (42,610) (38,107) (88,569) (72,860)
Other income        
Interest income 6,495 6,610 11,656 12,838
Total other income 6,495 6,610 11,656 12,838
Net loss (36,115) (31,497) (76,913) (60,022)
Other comprehensive income (loss):        
Unrealized loss on available-for-sale securities (197) (193) (216) (1,153)
Total comprehensive loss $ (36,312) $ (31,690) $ (77,129) $ (61,175)
Net loss per share, basic (in dollars per share) $ (0.34) $ (0.34) $ (0.77) $ (0.66)
Net loss per share, diluted (in dollars per share) $ (0.34) $ (0.34) $ (0.77) $ (0.66)
Weighted-average shares outstanding, basic 104,940,493 93,515,356 100,062,373 90,541,332
Weighted-average shares outstanding, diluted 104,940,493 93,515,356 100,062,373 90,541,332